Literature DB >> 25573779

Host genetic variations in glutathione-S-transferases, superoxide dismutases and catalase genes influence susceptibility to malaria infection in an Indian population.

Rayzel C Fernandes1, Marriyah Hasan, Himanshu Gupta, K Geetha, Padmalatha S Rai, Manjunath H Hande, Sydney C D'Souza, Prabha Adhikari, Angela Brand, Kapaettu Satyamoorthy.   

Abstract

Antioxidant enzymes can contribute to disease susceptibility or determine response to therapy in individuals with malaria. Genetic variations due to polymorphisms in host genes encoding antioxidant enzymes such as glutathione S-transferases-theta, mu, pi (GSTT, GSTM, GSTP), superoxide dismutases (SOD) and catalase (CAT), may therefore, influence inter-individual response to malaria pathology and propensity of infection caused by Plasmodium vivax (Pv) and Plasmodium falciparum (Pf). Therefore, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing, we investigated the association of deletions of GSTT1 and GSTM1, single nucleotide polymorphisms (SNPs) of GSTP1 (rs1695), SOD1 (rs2234694), SOD2 (rs4880, rs1141718), SOD3 (rs2536512) and CAT (rs1001179) in individuals infected with Pf (n = 100) and Pv (n = 100) against healthy controls (n = 150). Our data suggest a significant role for GSTM1 deletions in complicated Pv (p = 0.0007) malaria with ODDs ratio 3.8 [with 95 % confidence interval (CI) 1.9-7.4]. The results also indicated that polymorphisms present in GSTP1, SOD1 and CAT genes may be associated with malaria susceptibility (p < 0.05), whereas SOD3 polymorphism may play a role in malarial resistance (p < 0.05). In addition, we observed significant SNP-SNP interactions with synergistic genetic effects in SOD2, SOD3 and CAT genes for Pv and in SOD2 and SOD3 genes for Pf. In conclusion, our results provide convincing evidence for a relationship between polymorphisms in host antioxidant enzymes and susceptibility to malaria infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25573779     DOI: 10.1007/s00438-014-0984-4

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  74 in total

1.  Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria.

Authors:  O Erel; H Vural; N Aksoy; G Aslan; M Ulukanligil
Journal:  Clin Biochem       Date:  2001-06       Impact factor: 3.281

2.  MnSOD polymorphisms in sensitized patients with delayed-type hypersensitivity reactions to the chemical allergen para-phenylene diamine: a case-control study.

Authors:  Richard Brans; Heinrich Dickel; Thomas Bruckner; Pieter-Jan Coenraads; Michael Heesen; Hans F Merk; Brunhilde Blömeke
Journal:  Toxicology       Date:  2005-09-01       Impact factor: 4.221

3.  Interplay between glutathione-S-transferase and glucose-6-phosphate dehydrogenase in neonatal cord blood.

Authors:  A A Hunaiti; M al-Shareef
Journal:  Biol Neonate       Date:  1997

Review 4.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

5.  GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese.

Authors:  Xiuchan Guo; Stephen J O'Brien; Yi Zeng; George W Nelson; Cheryl A Winkler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

Review 6.  Human glutathione S-transferases.

Authors:  R Whalen; T D Boyer
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

Review 7.  Glucose-6-phosphate dehydrogenase deficiency and malaria.

Authors:  C Ruwende; A Hill
Journal:  J Mol Med (Berl)       Date:  1998-07       Impact factor: 4.599

8.  Placental malarial infection as a risk factor for hypertensive disorders during pregnancy in Africa: a case-control study in an urban area of Senegal, West Africa.

Authors:  C T Ndao; A Dumont; N Fievet; S Doucoure; A Gaye; J Y Lehesran
Journal:  Am J Epidemiol       Date:  2009-08-13       Impact factor: 4.897

9.  Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease.

Authors:  D E Goldberg; A F Slater; R Beavis; B Chait; A Cerami; G B Henderson
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

Review 10.  Clinical review: Severe malaria.

Authors:  Andrej Trampuz; Matjaz Jereb; Igor Muzlovic; Rajesh M Prabhu
Journal:  Crit Care       Date:  2003-04-14       Impact factor: 9.097

View more
  2 in total

Review 1.  Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy.

Authors:  Antonio Rafael Quadros Gomes; Natasha Cunha; Everton Luiz Pompeu Varela; Heliton Patrick Cordovil Brígido; Valdicley Vieira Vale; Maria Fâni Dolabela; Eliete Pereira De Carvalho; Sandro Percário
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

2.  Genetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum.

Authors:  Himanshu Gupta; Sima Chaudhari; Ayushi Rai; Smitha Bhat; Pratima K Sahu; Manjunath H Hande; Sydney C D'Souza; Umakanth Shashikiran; Kapaettu Satyamoorthy
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.